LBO — ST. JOSEPHS MEDICAL CENTER
IRR: 20.9% | MOIC: 2.59x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
20.9%
IRR
2.59x
MOIC
$431.8M
Entry EV
$768.2M
Exit EV
$222.2M
Equity Invested
Sources & Uses
S&UTotal · $431.8M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $167.7M | 38.8% | |
| Sub Debt | $41.9M | 9.7% | |
| Equity | $222.2M | 51.5% | |
| Enterprise Value | $419.2M | 97.1% | |
| Transaction Fees | $12.6M | 2.9% | |
| Total Uses | $431.8M | 100.0% |
Interpretation
INTAt 2.59x MOIC and 20.9% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $73.2M |
| Exit Ev | $768.2M |
| Net Debt At Exit | $193.2M |
| Equity At Exit | $575.0M |
| Equity Invested | $222.2M |
| Total Value Created | $352.8M |
| Value From Growth | $328.0M |
| Value From Multiple | $21.0M |
| Value From Deleveraging | $16.4M |